Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 4, Pages e60817
Publisher
Public Library of Science (PLoS)
Online
2013-04-09
DOI
10.1371/journal.pone.0060817
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
- (2012) Eveline M. Dijkgraaf et al. CURRENT PHARMACEUTICAL DESIGN
- Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells
- (2012) Yue Wang et al. CYTOKINE
- Inflammation and ovarian cancer
- (2012) Antonio Macciò et al. CYTOKINE
- Minocycline inhibits growth of epithelial ovarian cancer
- (2012) Mohammad H. Pourgholami et al. GYNECOLOGIC ONCOLOGY
- Minocycline Inhibits Alkali Burn-Induced Corneal Neovascularization in Mice
- (2012) Ou Xiao et al. PLoS One
- STAT3 negatively regulates thyroid tumorigenesis
- (2012) J. P. Couto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic Targeting of the Interleukin-6 Receptor
- (2011) Toshio Tanaka et al. Annual Review of Pharmacology and Toxicology
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Matrix Metalloproteinase Inhibitors Attenuate Neuroinflammation Following Focal Cerebral Ischemia in Mice
- (2011) Cheol Hong Park et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Rapid Phospho-Turnover by Receptor Tyrosine Kinases Impacts Downstream Signaling and Drug Binding
- (2011) Laura B. Kleiman et al. MOLECULAR CELL
- Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS
- (2011) Jennifer H. Campbell et al. PLoS One
- Gingival Fibroblasts Display Reduced Adhesion and Spreading on Extracellular Matrix: A Possible Basis for Scarless Tissue Repair?
- (2011) Fen Guo et al. PLoS One
- Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects
- (2011) Christopher J Smith et al. ARTHRITIS RESEARCH & THERAPY
- Anti-inflammatory properties of Doxycycline and Minocycline in experimental models: an in vivo and in vitro comparative study
- (2011) Liz M. Leite et al. INFLAMMOPHARMACOLOGY
- Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells
- (2010) Jiunn-Min Shieh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2010) Yue Wang et al. CANCER LETTERS
- IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
- (2010) Chi-Wen Lo et al. CANCER RESEARCH
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
- (2010) T. B. Dorff et al. CLINICAL CANCER RESEARCH
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells
- (2010) Chih-Ping Hsu et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- gp130 at the nexus of inflammation, autoimmunity, and cancer
- (2010) J. S. Silver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model
- (2010) Zhi-You Cai et al. Neuroscience Bulletin
- STAT3 Regulation of Glioblastoma Pathogenesis
- (2009) Nuria la Iglesia et al. CURRENT MOLECULAR MEDICINE
- Tocilizumab Inhibits Interleukin-6-Mediated Matrix Metalloproteinase-2 and -9 Secretions from Human Amnion Cells in Preterm Premature Rupture of Membranes
- (2009) Yukio Mano et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
- (2008) Zhenfeng Duan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1
- (2008) Catherine M. Cahill et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL–1β-stimulated activation of ERK1/2 and p38α MAPK mediates the transcriptional up-regulation of IL–6, IL–8 and GRO-α in HeLa cells
- (2007) Huei-Ting Yang et al. CELLULAR SIGNALLING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now